Related Experiment Video
Updated: May 25, 2026
06:37
Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
Published on: September 13, 2024
A potential relationship between diffuse musculoskeletal pain and hypogonadism
Jaclyn K Anderson1, Rebecca Tuetken, Valerie Hoffman
1University of Nebraska Medical Center, Department of Internal Medicine, Section of Rheumatology and Immunology, 983025 Nebraska Medical Center, Omaha, Nebraska, 68198-3025, USA.
BMJ Case Reports
|January 14, 2012
Summary
Men with diffuse musculoskeletal pain and low testosterone (male hypogonadism) showed a negative correlation between pain duration and testosterone levels. Further research is needed to confirm this link and the effects of testosterone replacement therapy.
Area of Science:
- Endocrinology
- Rheumatology
- Men's Health
Background:
- Some men experience diffuse musculoskeletal pain alongside low testosterone levels.
- Existing research on testosterone replacement therapy for functional status in these men is limited.
- No studies have specifically investigated the correlation between diffuse musculoskeletal pain and male hypogonadism.
Purpose of the Study:
- To explore the potential correlation between diffuse musculoskeletal pain and male hypogonadism.
- To investigate the relationship between pain duration and baseline testosterone levels in hypogonadal men.
Main Methods:
- A cohort of 45 hypogonadal men with diffuse musculoskeletal pain was studied.
- Baseline total testosterone values and pain duration in years were recorded.
- Statistical analysis was performed to identify correlations.
Main Results:
- A negative correlation was observed between the duration of pain (in years) and baseline total testosterone values.
- Age and other examined variables were not independently associated with baseline testosterone levels.
Conclusions:
- The findings suggest a potential link between prolonged diffuse musculoskeletal pain and lower testosterone levels in hypogonadal men.
- Generalised screening for gonadal function is not currently indicated for these patients.
- Prospective studies are necessary to further evaluate the relationship and the efficacy of testosterone replacement therapy.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:37Hypothalamic-Pituitary Axis
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...